CLOVER HEALTH INVESTMENTS, CORP. /DE Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) reported Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount of $7.19 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance · last filed 2026-02-27
- CLOVER HEALTH INVESTMENTS, CORP. /DE effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount for fiscal 2025 was $7.19M, a 84.17% increase from fiscal 2024.
- CLOVER HEALTH INVESTMENTS, CORP. /DE effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount for fiscal 2024 was $3.90M, a 85.74% decline from fiscal 2023.
- CLOVER HEALTH INVESTMENTS, CORP. /DE effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount for fiscal 2023 was $27.38M, a 70.77% decline from fiscal 2022.
- CLOVER HEALTH INVESTMENTS, CORP. /DE effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount for fiscal 2022 was $93.67M, a 16.86% decline from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount 12 month |
|---|---|
| 2025-12-31 | $7.19M 10-K · filed 2026-02-27 |
| 2024-12-31 | $3.90M 10-K · filed 2026-02-27 |
| 2023-12-31 | $27.38M 10-K · filed 2026-02-27 |
| 2022-12-31 | $93.67M 10-K · filed 2025-03-03 |
| 2021-12-31 | $112.66M 10-K · filed 2024-03-14 |
| 2020-12-31 | $18.59M 10-K · filed 2023-03-01 |
| 2019-12-31 | $39.64M 10-K · filed 2022-02-28 |